2 min read
AGC Biologics
1 min read
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage
1 min read
AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site
2 min read
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
1 min read
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
2 min read
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)